|
Under
public scrutiny
The pharma and healthcare industry is booming in India, but
every good involves some bad. Social activists and NGOs act
as watchdogs, keeping the greater common good in mind. Sushmi
Dey explores their role
Drink
to success
Dabur India, recently launched Chywan Junior, and marked its
entry into the malted food, drinks segment. Garima Arora charts
the marketing initiatives behind the product
Disease
mapping
Hemogenomics is a name that has been instrumental in bringing
the urgently required NAT test to India. Sumit Bagaria, President,
Hemogenomics, tells Sriram Iyer about the years before and
after the company came into being
‘We
see ourselves as strategic partners for Indian customers’
In September, Degussa became the chemical business area of
Evonik Industries. As a brand new name in the international
business arena, Evonik continues to stand for excellence in
the global chemical business area. Dr Reiner Beste, Head-Business
Line Pharma Polymers, reveals more about the company to Sachin
Jagdale
Strategies
for the product patent regime
Implementation of the product patent regime calls for a change
in strategies. The most important aspect seems to be better
asset utilisation policies
ACG
acquires Croatian capsule firm
ACG Worldwide (formerly known as the Associated Capsules Group),
has recently announced the 100 percent equity acquisition
of Lukaps, Croatia.
Forbes
Marshall joins hands with Codel International
Forbes Marshall, a specialist in process efficiency and energy
conservation has recently announced a joint venture with Codel
International, UK, a company specialising in hi-tech online
gas and dust monitoring systems.
Two
new Millipore products to aid drug research
Millipore has announced the availability of ArthroMAB monoclonal
antibody cocktail, a kit researchers use to generate arthritis
mouse models.
|
